Connect with us

Press Releases

Essilor of America Announces AVA

This integrated solution will offer digital accuracy both in exam and prescription within 1/100th of diopter.

mm

Published

on

(PRESS RELEASE) NEW YORK – Essilor of America announced today the launch of AVA (Advanced Vision Accuracy), an integrated solution for eye care professionals enabled by the introduction of the new phoropter, the Vision-R 800 by Essilor Instruments. For the first time, this integrated offer will include breakthrough refraction technology, innovative user-friendly intelligence and premium advanced lenses which will give eye care professionals the ability to demonstrate and deliver the best vision possible for patients.

“At Essilor we are committed to giving eye care professionals an opportunity to differentiate themselves and their practices with our cutting-edge technology and revolutionary patient care solutions,” says Rick Gadd, president of Essilor of America.

Podcast: What the Heck is Marketing? And What Should ECPs Focus on to Attract New Clients?
INVISION Podcast

Podcast: What the Heck is Marketing? And What Should ECPs Focus on to Attract New Clients?

Podcast: More Ways to Motivate Your Own Eyecare Business Team
INVISION Podcast

Podcast: More Ways to Motivate Your Own Eyecare Business Team

Podcast: Why Can’t We All Just Get Along?
INVISION Podcast

Podcast: Why Can’t We All Just Get Along?

“The AVA solution integrates the new advanced phoropter and our best digital lens designs, to equip eye care professionals with the complete package, making the refraction more efficient, the prescription more precise, and the overall experience better for the patient.”

The new phoropter, the Vision-R 800, introduced by Essilor Instruments, represents a major advancement in refraction techniques, which have remained unchanged for nearly a century. This new advanced phoropter introduces a whole new standard of accuracy while maintaining an efficient and consistent refraction.

“The Vision- R 800 phoropter is a perfect example of what Essilor does best: innovating to improve lives by improving sight,” says Samy Lauriette, senior vice president, Essilor Instruments Americas.

A More Precise Refraction

Advertisement

The Vision-R 800’s patented optical module allows for instant focus and exact refraction. It offers a refractive power of 0.01D steps and instantaneous changes of sphere, cylinder and axis at the same time for unparalleled accuracy. The precise Rx will be delivered through our best digital lens designs – Varilux® and Eyezen+, which will be available to be ordered to 0.01D in the second quarter of this year. The result is patients get the full potential of their vision.

A Fully Reliable Prescription

With the Vision-R 800, the refraction experience is transformed – for both the patient and the practitioner. The practitioner reaches the final refraction more quickly than with traditional methods thanks to the continuous and simultaneous changes of sphere power, cylinder axis and cylinder power. Also, the module’s “Smart Tests” algorithm assists the specialist in conducting the refraction procedure, making it both fast and easy, allowing the practitioner to focus on having a dialogue with the patient.

A More Comfortable Experience for the Patient

The Vision-R 800 uses a revolutionary new liquid lens and a new refractive process that makes the experience more comfortable for the patient and less tedious for the doctor. The phoropter’s smooth power changes and wider field of vision allow for a shorter procedure with less fatigue for the patient and doctor. At the end of the test, the Vision-R 800 phoropter offers patients the experience of comparing refractions in simulated real life conditions.

“The ultra-precise Rx can be demonstrated as never before to the patient with a fascinating simulation-based experience. This should especially appeal to younger patients,” says Lauriette. “The result is a patient who leaves the exam room with full confidence. And by clearly seeing the improvement they are more likely to purchase new eyewear.”

Advertisement

“We’re the only company that can guarantee digital accuracy in both exams and prescriptions – with the world’s most advanced lenses in our Varilux and Eyezen+ designs that can be ordered to the 1/100th of diopter in prescription,” says Sherianne James, senior vice president and chief marketing officer at Essilor of America. ”With this solution, eye care practitioners can deliver their patient’s best vision and equip them with an immediate demonstration of the power of precise lenses and the best visual acuity.”

Availability

The AVA Integrated Solution is available to practitioners at Vision Expo East, with delivery starting eight weeks after ordering and subject to scheduling. The commercial launch is slated for July 2019.

Advertisement

SPONSORED VIDEO

SPONSORED BY HOYA

Hoya: The Right Lenses for Sun Protection

Eye safety has never been more important--or fashionable. Check out Hoya's Serenity photochromic and Coppertone(R) polarized lens collections, just in time for summer!

Promoted Headlines

Press Releases

Morel’s Wins the 25th Annual Communicator Award of Excellence

It wins the award in the B2B category.

mm

Published

on

(PRESS RELEASE) WYCKOFF, NJ — Morel, the French reference in eyewear, established in 1880, is very excited to receive a Communicator Award for the 2018 B2B campaign, See More, See Morel.

This international award was granted in recognition of Morel’s 360° communication campaign, launched at Silmo 2018. The new campaign features circles that are multicolor and fun, leaving an everlasting footprint. More than just an image, the circles blend Morel’s rich heritage and expertise in designs.

The Morel team is honored to accept the award and be on the lookout for the See More, See Morel campaign on Morel’s advertisements.

Continue Reading

Press Releases

Marcolin Group Announces Operational Changes

This is part of an agreed-upon plan between the parties involved.

mm

Published

on

Giovanni Zoppas

(PRESS RELEASE) LONGARONE, BL — Marcolin Group, one of the worldwide leading eyewear companies, announces that Giovanni Zoppas is leaving his responsibilities in the group, while still remaining as a director of the board.

Giovanni Zoppas moves on to Thélios in the role of CEO and general manager of the joint venture established by Marcolin with the LVMH Group.

This is part of an agreed-upon plan between the parties, aimed at maximizing the overall value of Marcolin Group.

Continue Reading

Press Releases

House Subcommittee Urges FTC to Modernize Contact Lens Verification Process

Patient safety advocates have repeatedly called attention to flaws in current rules related to prescription verification.

mm

Published

on

(PRESS RELEASE) WASHINGTON – The Health Care Alliance for Patient Safety (Alliance) this week expressed its support of the House Committee on Appropriations for urging the Federal Trade Commission (FTC) to update the process by which contact lens prescriptions are verified.

The Committee report, which accompanies the Financial Services and General Government (FSGG) funding bill, comes as the FTC is accepting additional public comments on the proposed Contact Lens Rule. Patient safety advocates have repeatedly called attention to flaws in current rules related to prescription verification.

The FSGG report, which can be read here, states:

Contact Lenses. — In May, the FTC released a Supplemental Notice of Proposed Rulemaking detailing potential adjustments to its proposed changes to the Contact Lens Rule. This ensures that the FTC will receive additional input from the public and stakeholders on potential improvements to the rule to address patient safety and enforcement mechanisms, among other issues. The Committee urges the FTC to address the need for the prescription verification process to be modernized to provide for adequate enforcement of the law.

Thomas Swinnen, North America President of Johnson & Johnson Vision Care, Inc. and member of the Alliance, stated, “This report language reflects the importance of amplifying patient eye health and safety issues with policymakers. We’re pleased that the Committee recognizes the need to modernize the prescription verification process—a critical step in maintaining the doctor-patient relationship at the center of patient care.”

For several years, Alliance members and patient safety advocates have called for updated verification methods that would ensure patients receive the proper medical devices they were prescribed by their eye care professional.

In 2018, the Alliance submitted comments to the FTC that highlighted the problems with the current prescription verification system. The comments read, in part, “FTC action to modernize its guidance around passive-verification communication while excluding antiquated technology (e.g. robocalls) would provide greater documentation and the possibility of greater oversight in the [prescription] verification process. Greater oversight, understanding and documentation will ultimately create a safer and more efficient environment for contact lens wearers and the verification of their prescriptions through clearer, concise and accurate communication between the prescriber and the seller.”

“The doctor-patient relationship is central to the widespread enjoyment of contact lenses. A key part of that equation is ensuring what was prescribed is ultimately provided, as each contact lens is precisely selected for a patient’s specific vision and health needs,” said Michele Andrews, OD, Senior Director, North American Professional & Academic Affairs, CooperVision. “We are committed to advancing healthy contact lens wear for millions of consumers and encourage the FTC to share in this responsibility by addressing and fixing outmoded verification techniques.”

The Alliance encourages patients to share their stories of how antiquated technology in the prescription verification process has been detrimental to their vision health. To share your story and tell the FTC to protect patient safety, visit www.PatientSafetyToday.com/Share_Your_Story.

Deanna Alexander, OD, chairwoman of the Alliance, concluded, “For a significant period of time, patient safety advocates, like the members of the Alliance, have shared the potential dangers that could stem from the FTC’s current rules related to contact lens prescription verification. Now, as Congress makes it clear that they believe it’s time for a verification system that protects patients’ vision health, the Alliance is hopeful that the FTC will carefully consider adjustments to the Contact Lens Rule to better safeguard patients.”

Continue Reading

Advertisement

Advertisement

Advertisement

Subscribe


BULLETINS

Get the most important news and business ideas for eyecare professionals every weekday from INVISION.

Facebook

Most Popular